ISSN 2063-5346
For urgent queries please contact : +918130348310

Current and Future Prospective in Management of Tuberculosis

Main Article Content

Yash S.Chaudhari, Prashik P.Jamdhade, Mayuri R.Sawant ,Nutan S.Badhe, Dipti B.Thorat, Pramod S.Shinde, Sanika S.Pimpale, Sanchita R.Kokate
» doi: 10.48047/ecb/2023.12.Si9.302


One of the main causes of death worldwide, TB is a chronic, airborne bacterial infection brought on by the bacterium Mycobacterium tuberculosis. Symptoms include respiratory sickness and immune system impairment. The development of cross- or multidrug resistance, which makes therapy more difficult, as well as the major negative side effects of traditional synthetic therapeutic techniques have a negative influence on people's health. The Short Course (DOTS) programme, multidrug-resistant tuberculosis (MDRTB), unrestricted private health care resulting in widespread irrational use of first- and second-line anti-TB drugs, HIV coinfection, and unsatisfactory diagnostics and treatment are some of the main causes of the ongoing challenges in TB control. Natural goods have been and will continue to be a major source of cutting-edge treatments for a variety of diseases. It is possible to find novel molecules to prevent infection thanks to the revolutionary clinical care offered by antituberculotic medicinal plants. Growing interest in natural products in the search for new antitubercular leads is a result of the predominance of multidrug-resistant MTB strains and the negative effects of first- and second-line antitubercular drugs. Ayurvedic therapies drastically reduce TB patients' fatality rates, according to prior study. Due to its low toxicity and safety as compared to allopathic therapies, ayurvedic medicine is become most popular.

Article Details